Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy

por van Aken, Evert S. M., Beeker, Aart, Houtenbos, Ilse, Pos, Floris J., Linn, Sabine C., Elkhuizen, Paula H. M., de Jong, Monique C.
Publicado 2021

ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker

por Göttgens, Eva-Leonne, van den Heuvel, Corina NAM, de Jong, Monique C, Kaanders, Johannes HAM, Leenders, William PJ, Ansems, Marleen, Bussink, Johan, Span, Paul N
Publicado 2019

Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges

por van Aken, Evert S.M., van der Linden, Yvette M., van Thienen, Johannes V., de Langen, Adrianus J., Marijnen, Corrie A.M., de Jong, Monique C.
Publicado 2022

ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer

por Keulers, Tom G., Koch, Alexander, van Gisbergen, Marike W., Barbeau, Lydie M.O., Zonneveld, Marijke I., de Jong, Monique C., Savelkouls, Kim G.M., Wanders, Roel G., Bussink, Johan, Melotte, Veerle, Rouschop, Kasper M.A.
Publicado 2021

Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients

por van der Heijden, Martijn, de Jong, Monique C., Verhagen, Caroline V. M., de Roest, Reinout H., Sanduleanu, Sebastian, Hoebers, Frank, Leemans, C. René, Brakenhoff, Ruud H., Vens, Conchita, Verheij, Marcel, van den Brekel, Michiel W. M.
Publicado 2019

Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation

por van der Heijden, Martijn, Essers, Paul B. M., de Jong, Monique C., de Roest, Reinout H., Sanduleanu, Sebastian, Verhagen, Caroline V. M., Hamming-Vrieze, Olga, Hoebers, Frank, Lambin, Philippe, Bartelink, Harry, Leemans, C. René, Verheij, Marcel, Brakenhoff, Ruud H., van den Brekel, Michiel W. M., Vens, Conchita
Publicado 2020

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised contr...

por Lieverse, Relinde I. Y., Van Limbergen, Evert J., Oberije, Cary J. G., Troost, Esther G. C., Hadrup, Sine R., Dingemans, Anne-Marie C., Hendriks, Lizza E. L., Eckert, Franziska, Hiley, Crispin, Dooms, Christophe, Lievens, Yolande, de Jong, Monique C., Bussink, Johan, Geets, Xavier, Valentini, Vincenzo, Elia, Giuliano, Neri, Dario, Billiet, Charlotte, Abdollahi, Amir, Pasquier, David, Boisselier, Pierre, Yaromina, Ala, De Ruysscher, Dirk, Dubois, Ludwig J., Lambin, Philippe
Publicado 2020